A single-center study of hematopoietic stem cell transplantation for primary immune deficiencies (PIDD)

Pediatric Transplantation

Volumn 16, Issue 1, 2012, Pages 63-72

  Dinardo, Laura ^a   Brown, Valerie ^a   Perez, Elena ^a,b   Bunin, Nancy ^a   Sullivan, Kathleen E ^a  

^a Children's Hospital of Philadelphia   (United States)

^b JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

Author keywords

bone marrow; engraftment; hematopoietic stem cell transplantation; IVIG; outcomes; severe combined immune deficiency; transplant; X linked severe combined immune deficiency

Indexed keywords

ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; INFANT; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

BONE MARROW CELLS; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULINS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOPHENOTYPING; INFANT; INFANT, NEWBORN; MALE; PHILADELPHIA; REGISTRIES; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; X-LINKED COMBINED IMMUNODEFICIENCY DISEASES;

EID: 84856020403     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2011.01606.x     Document Type: Article

References (49)

1. Cavazzana-Calvo M, Carlier F, Le Deist F, et al., Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype. Blood 2007: 109: 4575-4581. (Pubitemid 46743429)
2. Railey MD, Lokhnygina Y, Buckley RH,. Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or post-transplant GVHD prophylaxis. J Pediatr 2009: 155: 834-840.
3. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA,. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 1994: 125: 876-885. (Pubitemid 24379120)
4. Albert MH, Bittner TC, Nonoyama S, et al., X-linked thrombocytopenia (XLT) due to WAS mutations: Clinical characteristics, long-term outcome, and treatment options. Blood 2010: 115: 3231-3238.
5. Hayward AR, Levy J, Facchetti F, et al., Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 1997: 158: 977-983. (Pubitemid 127492679)
6. I nternational U nion of I mmunological S ocieties E xpert C ommittee on P rimary I, Notarangelo LD, Fischer A, et al., Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 2009: 124: 1161-1178.
7. Fischer A, Le Deist F, Hacein-Bey-Abina S, et al., Severe combined immunodeficiency. A model disease for molecular immunology and therapy. Immunol Rev 2005: 203: 98-109. (Pubitemid 40179696)
8. Buckley RH,. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 2004: 22: 625-655. (Pubitemid 38680436)
9. Aiuti A, Cattaneo F, Galimberti S, et al., Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 2009: 360: 447-458.
10. Hacein-Bey-Abina S, Hauer J, Lim A, et al., Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2010: 363: 355-364.
11. Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M,. 20 years of gene therapy for SCID. Nat Immunol 2010: 11: 457-460.
12. Bertrand Y, Landais P, Friedrich W, et al., Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: A retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency. J Pediatr 1999: 134: 740-748. (Pubitemid 30186819)
13. Antoine C, Muller S, Cant A, et al., Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: Report of the European experience 1968-99. Lancet 2003: 361: 553-560. (Pubitemid 36207472)
14. Fischer A, Landais P, Friedrich W, et al., European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet 1990: 336: 850-854. (Pubitemid 20311334)
15. Gennery AR, Slatter MA, Grandin L, et al., Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: Entering a new century, do we do better? J Allergy Clin Immunol 2010: 126: 602-610.
16. Buckley RH, Schiff SE, Schiff RI, et al., Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999: 340: 508-516. (Pubitemid 29093286)
17. Myers LA, Patel DD, Puck JM, Buckley RH,. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 2002: 99: 872-878. (Pubitemid 34525548)
18. Buckley RH, Schiff RI, Schiff SE, et al., Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 1997: 130: 378-387. (Pubitemid 27492681)
19. Van Leeuwen JE, Van Tol MJ, Joosten AM, et al., Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency. Blood 1994: 84: 3936-3947. (Pubitemid 24362496)
20. Haddad E, Le Deist F, Aucouturier P, et al., Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: A single-center study of 22 patients. Blood 1999: 94: 2923-2930. (Pubitemid 29477323)
21. Friedrich W, Honig M, Muller SM,. Long-term follow-up in patients with severe combined immunodeficiency treated by bone marrow transplantation. Immunol Res 2007: 38: 165-173. (Pubitemid 47574905)
22. Patel DD, Gooding ME, Parrott RE, Curtis KM, Haynes BF, Buckley RH,. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 2000: 342: 1325-1332. (Pubitemid 30408717)
23. De Ravin SS, Malech HL,. Partially corrected X-linked severe combined immune deficeincy: Long term problems and treatment options. Immunol Res 2009: 43: 223-242.
24. Straathof KC, Rao K, Eyrich M, et al., Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: A phase 1/2 study. Lancet 2009: 374: 912-920.
25. Szabolcs P, Cavazzana-Calvo M, Fischer A, Veys P,. Bone marrow transplantation for primary immunodeficiency diseases. Pediatr Clin North Am 2010: 57: 207-237.
26. Servais S, Baron F, Beguin Y,. Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning. Transfus Apher Sci 2011: 44: 205-210.
27. Seidel MG, Fritsch G, Matthes-Martin S, et al., In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation. Haematologica 2005: 90: 1405-1414. (Pubitemid 41503657)
28. Shulman HM, Sullivan KM, Weiden PL, et al., Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980: 69: 204-217. (Pubitemid 10036817)
29. Sullivan KM, Shulman HM, Storb R, et al., Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 1981: 57: 267-276. (Pubitemid 11174888)
30. Glucksberg H, Storb R, Fefer A, et al., Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974: 18: 295-304.
31. Przepiorka D, Weisdorf D, Martin P, et al., 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995: 15: 825-828.
32. Norris R, Paessler M, Bunin N,. Donor T-cell-mediated pancytopenia after haploidentical hematopoietic stem cell transplant for severe combined immunodeficiency. J Pediatr Hematol Oncol 2009: 31: 148-150.
33. Leahey AM, Bunin NJ, Schears GJ, Smith CA, Flake AW, Sullivan KE,. Successful use of extracorporeal membrane oxygenation (ECMO) during BMT for SCID. Bone Marrow Transplant 1998: 21: 839-840. (Pubitemid 28190632)
34. Porta F, Forino C, De Martiis D, et al., Stem cell transplantation for primary immunodeficiencies. Bone Marrow Transplant 2008: 41 (Suppl 2): S83-S86. (Pubitemid 351864714)
35. Winkelstein JA, Marino MC, Ochs H, et al., The X-linked hyper-IgM syndrome: Clinical and immunologic features of 79 patients. Medicine (Baltimore) 2003: 82: 373-384. (Pubitemid 37445041)
36. Gennery AR, Khawaja K, Veys P, et al., Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: A survey of the European experience, 1993-2002. Blood 2004: 103: 1152-1157. (Pubitemid 38129585)
37. Levy J, Espanol-Boren T, Thomas C, et al., Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997: 131: 47-54. (Pubitemid 27498308)
38. Godthelp BC, Van Eggermond MC, Van Tol MJ, Vossen JM, Van Den Elsen PJ,. T cell immune reconstitution after allogeneic bone marrow transplantation in bare lymphocyte syndrome. Hum Immunol 2000: 61: 898-907.
39. Klein C, Cavazzana-Calvo M, Le Deist F, et al., Bone marrow transplantation in major histocompatibility complex class II deficiency: A single-center study of 19 patients. Blood 1995: 85: 580-587.
40. Mazzolari E, De Martiis D, Forino C, et al., Single-center analysis of long-term outcome after hematopoietic cell transplantation in children with congenital severe T cell immunodeficiency. Immunol Res 2009: 44: 4-17.
41. Dror Y, Gallagher R, Wara DW, et al., Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation. Blood 1993: 81: 2021-2030. (Pubitemid 23106715)
42. Haddad E, Landais P, Friedrich W, et al., Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: A European retrospective study of 116 patients. Blood 1998: 91: 3646-3653. (Pubitemid 28225731)
43. Buckley RH,. B-cell function in severe combined immunodeficiency after stem cell or gene therapy: A review. J Allergy Clin Immunol 2010: 125: 790-797.
44. Kuchen S, Robbins R, Sims GP, et al., Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J Immunol 2007: 179: 5886-5896.
45. Zotos D, Coquet JM, Zhang Y, et al., IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J Exp Med 2010: 207: 365-378.
46. Shah AJ, Kohn DB,. Neurocognitive function of patients with severe combined immunodeficiency. Immunol Allergy Clin North Am 2010: 30: 143-151.
47. Lin M, Epport K, Azen C, Parkman R, Kohn DB, Shah AJ,. Long-term neurocognitive function of pediatric patients with severe combined immune deficiency (SCID): Pre- and post-hematopoietic stem cell transplant (HSCT). J Clin Immunol 2009: 29: 231-237.
48. Patel NC, Chinen J, Rosenblatt HM, et al., Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning. J Allergy Clin Immunol 2009: 124: 1062-1069 e1061-1064.
49. Patel NC, Chinen J, Rosenblatt HM, et al., Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb. J Allergy Clin Immunol 2008: 122: 1185-1193.